Ligne de temps

Yu Wei
Chef(fe) de Groupe
19 déc. 2023
publication

NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathway.

Lire plus
21 déc. 2022
publication

Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters

Lire plus
28 sept. 2016
publication

Single-nucleotide-resolution mapping of HBV promoters in infected human livers and hepatocellular carcinoma

Lire plus
05 nov. 2015
publication

Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress

Lire plus
06 juil. 2015
project

Molecular mechanisms regulating hepatitis B virus replication and liver carcinogenesis

Lire plus
01 août 2013
publication

LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis.

Lire plus
28 févr. 2013
publication

The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b

Lire plus
15 janv. 2013
publication

The four and a half LIM-only protein 2 (FHL2) activates transforming growth factor β (TGF-β) signaling by regulating ubiquitination of the E3 ligase Arkadia

Lire plus
11 juil. 2012
publication

The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis

Lire plus
18 mai 2010
publication

Molecular biology of the hepatitis B virus and role of the X gene

Lire plus
28 avr. 2010
publication

Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice

Lire plus
01 déc. 2008
publication

Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer

Lire plus
19 nov. 2008
publication

The LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways

Lire plus
31 mars 2008
publication

The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation

Lire plus
01 févr. 2007
publication

Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer

Lire plus
01 mai 2006
publication

The LIM-only protein FHL2 is a negative regulator of E4F1

Lire plus
13 févr. 2003
publication

Identification of the LIM protein FHL2 as a coactivator of beta-catenin

Lire plus
01 sept. 2002
publication

Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features

Lire plus
01 juin 2002
publication

Genetic alterations and oncogenic pathways in hepatocellular carcinoma

Lire plus
27 janv. 2000
publication

Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas

Lire plus
01 sept. 1999
publication

Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation

Lire plus